4
Changes in Ownership
Immunome Inc. Filed Acc 0001997584-26-000002
Chief Medical Officer sold 55,000 shares at an average $19.85 ($1,091,662)
- Chief Medical Officer acquired 55,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lechleider Robert Chief Medical Officer | 2026-06-25 | Option exercise 10b5-1 | +55,000 | $8.73 | $480,150 | 70,805 | D: show line 1 in the form |
| Lechleider Robert Chief Medical Officer | 2026-06-25 | Sale 10b5-1 | −40,580 | $19.56 | $793,745 | 30,225 | D: show line 2 in the form |
| Lechleider Robert Chief Medical Officer | 2026-06-25 | Sale 10b5-1 | −14,420 | $20.66 | $297,917 | 15,805 | D: show line 3 in the form |
| Open-market sales · 55,000 sh · avg $19.85 · $1,091,662 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lechleider Robert Chief Medical Officer | 2026-06-25 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −55,000 | 345,000 | D: show line 4 in the form |
Loading xslF345X06/form4-06292026_080646.xml…